摘要
目的:探讨微导管在原发性肝癌化疗性栓塞中的应用价值。方法:应用微导管对29例原发性肝癌患者行供血动脉超选择化疗栓塞术。结果:本组29例共行化疗性栓塞41次,术后血清AFP下降大于50%者24例(82.8%),肿瘤缩小>50%者6例(20.7%),肿瘤缩小在25%～50%者16例(55.2%),其余患者肿瘤体积无明显变化。术后肝功能损害轻微,无严重并发症。结论:微导管超选择插管治疗肝癌操作简单、方便,超选择成功率高,疗效好,术后并发症少,具有十分重要的临床应用价值。
Objective： To investigate the value of microcatheter in chemoembolization of primary hepatocarcinoma （PHC）. Methods：Chemoembolization of feeding arteries of PHC was performed with microcatheter in 29 patients. Results：A total of 41 chemoembolization procedures were performed. Following transcatheter arterial chemoembolization （TACE）, reduction of serum AFP over 50% was found in 24 patients （82.8 %）,while tumor volume reduction over 50 % was found in 6 （20.7%） ,less than 50% but more than 25% in 16 （55.2%）. The damage to liver function was slight and no serious complications occurred. Conclusion：With microcatheter, the manipulation of TACE is simpler and easier, with a higher rate of success,efficacy and less complications. Microcatheter has great value in TACE therapy for PHC.
出处
《放射学实践》
2006年第6期611-613,共3页
Radiologic Practice
关键词
癌
肝细胞
放射学
介入性
化疗栓塞
治疗性
Carcinoma,hepatocellular
Radiology,interventional
Chemoembolization,therapeutic
